Physician

Kristi Robson, MD

According to 2025 Medicare claims, Kristi Robson, MD (NPI: 1730128653) practices dermatology in the Iowa City, IA market, with the plurality of this provider's patient population coming from Johnson, IA. This provider's primary affiliated billing organization is EPIPHANY DERMATOLOGY OF IOWA, PLC (NPI: 1104451749; TIN: 844900614) and primary practice location at 52241-1774.

Robson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 4,177 HCPCS/CPT codes, and received $153,178 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 788 prescription claims across 318 beneficiaries totaling $201,096 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 3 records totaling $53. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $79,292 to $153,178. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,797 to $201,096. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$77K$153K2015 Medicare payment: $79,292 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $90,720 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $92,295 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $108,200 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $107,382 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $100,195 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $138,021 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $130,745 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $143,567 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $153,178 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156672,780$79,292
20167743,347$90,720
20178513,288$92,295
20188913,799$108,200
20198723,392$107,382
20208332,993$100,195
20218973,599$138,021
20229233,485$130,745
20239513,794$143,567
20249194,177$153,178

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$101K$201K2015 Drug cost: $26,797 (USD; Tot_Drug_Cst)2016 Drug cost: $40,853 (USD; Tot_Drug_Cst)2017 Drug cost: $22,234 (USD; Tot_Drug_Cst)2018 Drug cost: $21,766 (USD; Tot_Drug_Cst)2019 Drug cost: $22,710 (USD; Tot_Drug_Cst)2020 Drug cost: $27,116 (USD; Tot_Drug_Cst)2021 Drug cost: $20,814 (USD; Tot_Drug_Cst)2022 Drug cost: $17,323 (USD; Tot_Drug_Cst)2023 Drug cost: $49,461 (USD; Tot_Drug_Cst)2024 Drug cost: $201,096 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015168336$26,797
2016184400$40,853
2017198395$22,234
2018223485$21,766
2019234488$22,710
2020217442$27,116
2021255548$20,814
2022253526$17,323
2023275582$49,461
2024318788$201,096

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths191235$74
11102Biopsy of related skin growth, first growth208241$62
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more8211,082$59
17000Destruction of precancer skin growth, 1 growth408551$38
17003Destruction of precancer skin growth, 2-14 growths2701,347$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept13364$87,017
Dupixent PenDupilumab22602$79,360
TacrolimusTacrolimus19535$2,474
KetoconazoleKetoconazole1223,452$2,389
Clobetasol PropionateClobetasol Propionate611,653$1,734

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$53PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kristi Robson, MD?

Tedicare shows public-source Medicare data for Kristi Robson, MD (NPI 1730128653), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristi Robson, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kristi Robson, MD?

Kristi Robson, MD is linked to EPIPHANY DERMATOLOGY OF IOWA, PLC (billing NPI 1104451749) in the available physician profile data.

Does Kristi Robson, MD have Open Payments data?

Kristi Robson, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.